These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 18666599

  • 21. Erythema infectiosum and other parvovirus B19 infections.
    Kirchner JT.
    Am Fam Physician; 1994 Aug; 50(2):335-41. PubMed ID: 8042568
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Seroepidemiology of Human Parvovirus B19 Infection among the Population of Vojvodina, Serbia, over a 16-Year Period (2008-2023).
    Vuković V, Patić A, Ristić M, Kovačević G, Hrnjaković Cvjetković I, Petrović V.
    Viruses; 2024 Jan 25; 16(2):. PubMed ID: 38399956
    [Abstract] [Full Text] [Related]

  • 24. The 1994 human parvovirus B19 epidemic in Denmark: diagnostic and epidemiological experience.
    Jensen IP, Schou O, Vestergaard BF.
    APMIS; 1998 Sep 25; 106(9):843-8. PubMed ID: 9808410
    [Abstract] [Full Text] [Related]

  • 25. Human B19 parvovirus infection in an obstetric population. A prospective study determining fetal outcome.
    Guidozzi F, Ballot D, Rothberg AD.
    J Reprod Med; 1994 Jan 25; 39(1):36-8. PubMed ID: 8169914
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Parvovirus B19 Seroprevalence in Women with Bad Obstetric History in Kirkuk.
    Alsamarai AM, Hassan HM, Alsamarai MA, Aljumaili ZK.
    Antiinflamm Antiallergy Agents Med Chem; 2021 Jan 25; 20(4):359-366. PubMed ID: 34315400
    [Abstract] [Full Text] [Related]

  • 28. Detection of human parvovirus B19 infection: a study of 212 suspected cases in the state of Rio de Janeiro, Brazil.
    Wermelinger MC, Oelemann WM, Lima de Mendonça MC, Naveca FG, von Hubinger MG.
    J Clin Virol; 2002 Aug 25; 25(2):223-30. PubMed ID: 12367658
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women.
    Hemauer A, Gigler A, Searle K, Beckenlehner K, Raab U, Broliden K, Wolf H, Enders G, Modrow S.
    J Med Virol; 2000 Jan 25; 60(1):48-55. PubMed ID: 10568763
    [Abstract] [Full Text] [Related]

  • 32. Prevalence of Parvovirus B19 Infection by Serology and PCR in Pregnant Women Referring to Obstetrics and Gynecology Clinic.
    Karami A, Hoseini SL, Ramazani A, Emadi P, Gholami H, Hoseini SM.
    J Natl Med Assoc; 2020 Feb 25; 112(1):91-96. PubMed ID: 30712919
    [Abstract] [Full Text] [Related]

  • 33. Prevalence of parvovirus B19-specific antibodies and of viral DNA in patients with endogenous uveitis.
    Heinz C, Plentz A, Bauer D, Heiligenhaus A, Modrow S.
    Graefes Arch Clin Exp Ophthalmol; 2005 Oct 25; 243(10):999-1004. PubMed ID: 15906067
    [Abstract] [Full Text] [Related]

  • 34. Seroepidemiology of parvovirus B19 in the Frankfurt am Main area, Germany: evaluation of risk factors.
    Reinheimer C, Allwinn R, Doerr HW, Wittek M.
    Infection; 2010 Oct 25; 38(5):381-5. PubMed ID: 20556472
    [Abstract] [Full Text] [Related]

  • 35. Parvovirus B19 antibodies in immunocompromized children in Thailand.
    Suandork P, Theamboonlers A, Likitnukul S, Hirsch P, Poovorawan Y.
    Asian Pac J Allergy Immunol; 2000 Sep 25; 18(3):161-4. PubMed ID: 11270472
    [Abstract] [Full Text] [Related]

  • 36. An epidemic of parvovirus B19 in a population of 3,596 pregnant women: a study of sociodemographic and medical risk factors.
    Jensen IP, Thorsen P, Jeune B, Møller BR, Vestergaard BF.
    BJOG; 2000 May 25; 107(5):637-43. PubMed ID: 10826579
    [Abstract] [Full Text] [Related]

  • 37. Incidence of parvovirus B19 infection among an unselected population of pregnant women in the Netherlands: A prospective study.
    van Gessel PH, Gaytant MA, Vossen AC, Galama JM, Ursem NT, Steegers EA, Wildschut HI.
    Eur J Obstet Gynecol Reprod Biol; 2006 May 25; 128(1-2):46-9. PubMed ID: 16406220
    [Abstract] [Full Text] [Related]

  • 38. Prolonged parvovirus b19 viremia in spite of neutralizing antibodies after erythema infectiosum in pregnancy.
    Dobec M, Juchler A, Flaviano A, Kaeppeli F.
    Gynecol Obstet Invest; 2007 May 25; 63(1):53-4. PubMed ID: 16940737
    [Abstract] [Full Text] [Related]

  • 39. Prevalence of antibodies to parvovirus B19 in selected groups of patients and healthy individuals.
    Schwarz TF, Hottenträger B, Roggendorf M.
    Zentralbl Bakteriol; 1992 Feb 25; 276(3):437-42. PubMed ID: 1576413
    [Abstract] [Full Text] [Related]

  • 40. Risk factors for parvovirus B19 infection in pregnancy.
    Valeur-Jensen AK, Pedersen CB, Westergaard T, Jensen IP, Lebech M, Andersen PK, Aaby P, Pedersen BN, Melbye M.
    JAMA; 1992 Feb 25; 281(12):1099-105. PubMed ID: 10188660
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.